DIAMOND BIOFUND INC.
鑽石生技投資股份有限公司
Added to the watchlist in this browser. Leave your email and we can let you know when this company changes.
2013Founded
NT$8.5BPaid-in capital
0Plants
NT$1–5BRevenue band
- Unified Business No.
- 53663724
- Industry
- Tobacco Manufacturing (1,186)
- Listing
- Listed (TWSE) (1,087) 6901
- Founded
- 2013-01-09
- Paid-in capital
- NT$ 8,533,600,000
- Phone
- 02-27031338
- Website
- https://www.diamondbiofund.com/
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$1–5B
- Ownership
- Group subsidiary / corporate-held · ONENESS BIOTECH CO., LTD.
- Representative tenure
- In office since 2024-08 (2 yrs); last handover 2024-08
- Growth & profitability
- Revenue 2026-09 YoY +959.2%, year-to-date +333.6%
Gross margin 100%, operating margin 97.6%, net margin 98.5% (2026-Q2 YTD)
Processes & materials 1
- Biotechnology (664) · Company nameSelf-reported
Similar companies 10
- Intelligene INC. Emerging stock (TPEx) NT$100–500M estimated
Shared: Biotechnology, Natural & engineering science R&D services - AP BIOSCIENCES INC. Listed (TPEx) < NT$20M estimated
Shared: Biotechnology, Other chemical materials & products wholesale n.e.c., Other professional, scientific & technical services n.e.c. - TAHO PHARMACEUTICALS LTD. Emerging stock (TPEx) < NT$20M
Shared: Biotechnology, Other professional, scientific & technical services n.e.c. - ORIGINAL BIOMEDICALS CO., LTD. Emerging stock (TPEx) NT$100–500M estimated
Shared: Other professional, scientific & technical services n.e.c., Natural & engineering science R&D services - BRIM BIOTECHNOLOGY INC. Listed (TWSE) < NT$20M
Shared: Other professional, scientific & technical services n.e.c., Natural & engineering science R&D services - TRIPARTITE THERAPEUTICS INC. Emerging stock (TPEx) NT$0.5–1B estimated
Shared: Natural & engineering science R&D services - YH Bio Co., Ltd. Public company (unlisted) NT$1–5B estimated
Shared: Biotechnology, Other professional, scientific & technical services n.e.c. - Han Kang Biotech Co. (Cayman) Listed (TWSE) NT$20–100M
Shared: Biotechnology - Chuan Yu Biotech Holdings Co., Ltd. Listed (TWSE) NT$1–5B
Shared: Biotechnology - PLEASANT HOTELS INTERNATIONAL INC. Listed (TPEx) NT$100–500M
Shared: Securities investment
Ranked by overlap in processes and materials, registered business activities, certifications and main products; rarer shared traits weigh more. Dissolved companies are excluded.